Pasithea Therapeutics Corp. (KTTAW) Change in Cash (2021 - 2026)

Pasithea Therapeutics has disclosed Change in Cash across 6 years of filings, most recently posting -$4.7 million for Q2 2026.

• In Q2 2026, Change in Cash fell 352.5% year-over-year to -$4.7 million; the TTM figure through Jun 2026 stood at $38.5 million (up 5236.2% YoY), while the FY2025 annual figure was $48.3 million, up 613.77% from the prior year.
• Change in Cash came in at -$4.7 million for Q2 2026 at Pasithea Therapeutics, roughly flat from -$4.8 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $51.0 million in Q4 2025 to a low of -$9.3 million in Q4 2022.
• Average Change in Cash over 5 years is -$396492.4, with a median of -$3.2 million recorded in 2023.
• Year-over-year, Change in Cash sank 423.6% in 2022 and surged 2192.99% in 2025.
• Over 5 years, Change in Cash stood at -$9.3 million in 2022, then soared by 64.98% to -$3.3 million in 2023, then grew by 25.05% to -$2.4 million in 2024, then surged by 2192.99% to $51.0 million in 2025, then plunged by 109.28% to -$4.7 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$4.7 million in Q2 2026, -$4.8 million in Q1 2026, and $51.0 million in Q4 2025.